Work

Abstract PS5-11-23: Timing of Oncotype DX Testing and Its Impact on Treatment Initiation in ER+/HER2-/N0 Breast Cancer Patients

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-11-23

Authors: E. Kohilakis, J. Taylor, S. Jao, E. Hakim, M. Rony, L. Coe, S. Harbour, N. Degrezia, A. Brooks, S. Feldman, A. Gupta, E. Ravetch, M. Sheckley, M. McEvoy

Institutions: Montefiore Medical Center, Albert Einstein College of Medicine

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129538702

Cites:

Cited by:

Related to: